Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the RNA Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sangamo Therapeutics
Ethris
Argos Therapeutics
eTheRNA
Tiba Biotechnology
CureVac
In-Cell-Art
Moderna Therapeutics
BioNTech
By Type:
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
By Application:
Infectious Disease
Other
Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China RNA Vaccines Market Overview 2018-2029
-
1.1 China RNA Vaccines Industry Development Overview
-
1.2 China RNA Vaccines Industry Development History
-
1.3 China RNA Vaccines Industry Market Size (2018-2029)
-
1.4 China RNA Vaccines Market Analysis by Type from Production Side
-
1.4.1 China RNA Vaccines Production Volume, Production Value and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2018-2029)
-
1.4.2 China RNA Vaccines Production Volume, Production Value and Growth Rate of Infection Prevention MRNA Vaccine (2018-2029)
-
1.4.3 China RNA Vaccines Production Volume, Production Value and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2018-2029)
-
1.5 China RNA Vaccines Market Analysis by Application from Consumption End
-
1.5.1 China RNA Vaccines Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)
-
1.5.2 China RNA Vaccines Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.3 China RNA Vaccines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.6 China RNA Vaccines Market Analysis by Region
-
1.6.1 North China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.3 South China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.4 East China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China RNA Vaccines Market Size and Growth Rate from 2018-2029
Chapter 2 China RNA Vaccines Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on RNA Vaccines Market Status and Competition at home and abroad in 2023
-
2.2.2 China RNA Vaccines Market Status and Competition Analysis in 2023
-
2.2.3 China RNA Vaccines Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China RNA Vaccines Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on RNA Vaccines Industry Development
Chapter 3 RNA VaccinesIndustry Chain Analysis
-
3.1 RNA Vaccines Industry Chain
-
3.2 RNA Vaccines Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the RNA Vaccines Market
-
3.3 RNA Vaccines Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the RNA Vaccines Market
Chapter 4 China RNA Vaccines Market, by Type
-
4.1 China RNA Vaccines Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China RNA Vaccines Total Production Volume and Growth Rate from Production Side
-
4.5 China RNA Vaccines Production Volume and Growth Rate, by Type
-
4.5.1 China RNA Vaccines Production Volume and Growth Rate of Infectious Disease Treatment MRNA Vaccine
-
4.5.2 China RNA Vaccines Production Volume and Growth Rate of Infection Prevention MRNA Vaccine
-
4.5.3 China RNA Vaccines Production Volume and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
Chapter 5 China RNA Vaccines Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China RNA Vaccines Total Market Size and Growth Rate from Consumption End
-
5.5 China RNA Vaccines Market Size and Growth Rate, by Application
-
5.5.1 China RNA Vaccines Market Size and Growth Rate of Infectious Disease
-
5.5.2 China RNA Vaccines Market Size and Growth Rate of Other
-
5.5.3 China RNA Vaccines Market Size and Growth Rate of Cancer
Chapter 6 China RNA Vaccines Market, by Region
-
6.1 China RNA Vaccines Production Volume and Production Value, by Region
-
6.2 China RNA Vaccines Sales Volume and Sales Value, by Region
Chapter 7 North China RNA Vaccines Market Analysis
-
7.1 North China RNA Vaccines Market, by Type
-
7.2 North China RNA Vaccines Market, by Application
Chapter 8 Central China RNA Vaccines Market Analysis
-
8.1 Central China RNA Vaccines Market, by Type
-
8.2 Central China RNA Vaccines Market, by Application
Chapter 9 South China RNA Vaccines Market Analysis
-
9.1 South China RNA Vaccines Market, by Type
-
9.2 South China RNA Vaccines Market, by Application
Chapter 10 East China RNA Vaccines Market Analysis
-
10.1 East China RNA Vaccines Market, by Type
-
10.2 East China RNA Vaccines Market, by Application
Chapter 11 Northeast China RNA Vaccines Market Analysis
-
11.1 Northeast China RNA Vaccines Market, by Type
-
11.2 Northeast China RNA Vaccines Market, by Application
Chapter 12 Southwest China RNA Vaccines Market Analysis
-
12.1 Southwest China RNA Vaccines Market, by Type
-
12.2 Southwest China RNA Vaccines Market, by Application
Chapter 13 Northwest China RNA Vaccines Market Analysis
-
13.1 Northwest China RNA Vaccines Market, by Type
-
13.2 Northwest China RNA Vaccines Market, by Application
Chapter 14 Company Profiles
-
14.1 Sangamo Therapeutics
-
14.1.1 Sangamo Therapeutics Company Profile
-
14.1.2 Sangamo Therapeutics RNA Vaccines Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Ethris
-
14.2.1 Ethris Company Profile
-
14.2.2 Ethris RNA Vaccines Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Argos Therapeutics
-
14.3.1 Argos Therapeutics Company Profile
-
14.3.2 Argos Therapeutics RNA Vaccines Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 eTheRNA
-
14.4.1 eTheRNA Company Profile
-
14.4.2 eTheRNA RNA Vaccines Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Tiba Biotechnology
-
14.5.1 Tiba Biotechnology Company Profile
-
14.5.2 Tiba Biotechnology RNA Vaccines Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 CureVac
-
14.6.1 CureVac Company Profile
-
14.6.2 CureVac RNA Vaccines Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 In-Cell-Art
-
14.7.1 In-Cell-Art Company Profile
-
14.7.2 In-Cell-Art RNA Vaccines Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Moderna Therapeutics
-
14.8.1 Moderna Therapeutics Company Profile
-
14.8.2 Moderna Therapeutics RNA Vaccines Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 BioNTech
-
14.9.1 BioNTech Company Profile
-
14.9.2 BioNTech RNA Vaccines Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 RNA Vaccines Industry Research Conclusions
-
15.2 RNA Vaccines Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China RNA Vaccines Industry Market Size (2018-2029)
-
Figure China RNA Vaccines Production Volume, Production Value and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2018-2029)
-
Figure China RNA Vaccines Production Volume, Production Value and Growth Rate of Infection Prevention MRNA Vaccine (2018-2029)
-
Figure China RNA Vaccines Production Volume, Production Value and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2018-2029)
-
Figure China RNA Vaccines Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)
-
Figure China RNA Vaccines Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China RNA Vaccines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure North China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Central China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure South China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure East China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Northeast China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Southwest China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Northwest China RNA Vaccines Market Size and Growth Rate from 2018-2029
-
Figure RNA Vaccines Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China RNA Vaccines Market Share by Type in 2018
-
Figure China RNA Vaccines Market Share by Type in 2023
-
Figure China RNA Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China RNA Vaccines Production Volume and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2018-2023)
-
Figure China RNA Vaccines Production Volume and Growth Rate of Infection Prevention MRNA Vaccine (2018-2023)
-
Figure China RNA Vaccines Production Volume and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2018-2023)
-
Figure China RNA Vaccines Market Share by Application in 2018
-
Figure China RNA Vaccines Market Share by Application in 2023
-
Figure China RNA Vaccines Total Market Size and Growth Rate from Consumption End
-
Figure China RNA Vaccines Market Size and Growth Rate of Infectious Disease (2018-2023)
-
Figure China RNA Vaccines Market Size and Growth Rate of Other (2018-2023)
-
Figure China RNA Vaccines Market Size and Growth Rate of Cancer (2018-2023)
-
Table China RNA Vaccines Production Volume by Region (2018-2023)
-
Table China RNA Vaccines Production Volume Share by Region (2018-2023)
-
Figure China RNA Vaccines Production Volume Share by Region (2018-2023)
-
Table China RNA Vaccines Production Value by Region (2018-2023)
-
Table China RNA Vaccines Production Value Share by Region (2018-2023)
-
Figure China RNA Vaccines Production Value Share by Region (2018-2023)
-
Table China RNA Vaccines Sales Volume by Region (2018-2023)
-
Table China RNA Vaccines Sales Volume Share by Region (2018-2023)
-
Figure China RNA Vaccines Sales Volume Share by Region (2018-2023)
-
Table China RNA Vaccines Sales Value by Region (2018-2023)
-
Table China RNA Vaccines Sales Value Share by Region (2018-2023)
-
Figure China RNA Vaccines Sales Value Share by Region (2018-2023)
-
Table North China RNA Vaccines Production Volume by Type (2018-2023)
-
Table North China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure North China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table North China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table North China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure North China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table Central China RNA Vaccines Production Volume by Type (2018-2023)
-
Table Central China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure Central China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table Central China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table Central China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Central China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table South China RNA Vaccines Production Volume by Type (2018-2023)
-
Table South China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure South China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table South China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table South China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure South China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table East China RNA Vaccines Production Volume by Type (2018-2023)
-
Table East China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure East China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table East China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table East China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure East China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table Northeast China RNA Vaccines Production Volume by Type (2018-2023)
-
Table Northeast China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure Northeast China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table Northeast China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table Northeast China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Northeast China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table Southwest China RNA Vaccines Production Volume by Type (2018-2023)
-
Table Southwest China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure Southwest China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table Southwest China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table Southwest China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Southwest China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table Northwest China RNA Vaccines Production Volume by Type (2018-2023)
-
Table Northwest China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Figure Northwest China RNA Vaccines Production Volume Share by Type (2018-2023)
-
Table Northwest China RNA Vaccines Sales Volume by Application (2018-2023)
-
Table Northwest China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Northwest China RNA Vaccines Sales Volume Share by Application (2018-2023)
-
Table Sangamo Therapeutics Company Profile
-
Table Sangamo Therapeutics RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table Ethris Company Profile
-
Table Ethris RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table Argos Therapeutics Company Profile
-
Table Argos Therapeutics RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table eTheRNA Company Profile
-
Table eTheRNA RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table Tiba Biotechnology Company Profile
-
Table Tiba Biotechnology RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table CureVac Company Profile
-
Table CureVac RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table In-Cell-Art Company Profile
-
Table In-Cell-Art RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table Moderna Therapeutics Company Profile
-
Table Moderna Therapeutics RNA Vaccines Revenue, Price and Gross (2018-2023)
-
Table BioNTech Company Profile
-
Table BioNTech RNA Vaccines Revenue, Price and Gross (2018-2023)
-
